Pre-made Idarucizumab benchmark antibody ( Fab, anti-Dabigatran therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Idarucizumab biosimilar, Fab: Anti-Dabigatran therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-261-1mg	1mg	3090
GMP-Bios-ab-261-10mg	10mg	Inquiry
GMP-Bios-ab-261-100mg	100mg	Inquiry
GMP-Bios-ab-261-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Idarucizumab biosimilar, Fab: Anti-Dabigatran therapeutic antibody
INN Name	Idarucizumab
Target	Dabigatran
Format	Fab
Derivation	Humanized
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Approved
Est. Status	NFD
100% SI Structure	4jn2:HL:BA/4jn1:HL
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2013
Year Recommended	2014
Companies	Boehringer Ingelheim
Conditions Approved	Blood coagulation disorders
Conditions Active	na
Conditions Discontinued	na
Development Tech	na